Last Price$18.49NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/14/22

Today's Change-0.42(2.22%)
Bid (Size)$18.49 (21)
Ask (Size)$18.54 (13)
Day Low / High$17.65 - 18.85
Volume196.1 K

View Biotechnology IndustryPeer Comparison as of 01/14/2022


MeiraGTx Holdings PLC ( NASDAQ )

Price: $18.49
Change: -0.42 (2.22%)
Volume: 196.1 K
4:00PM ET 1/14/2022

Vanda Pharmaceuticals Inc ( NASDAQ )

Price: $15.00
Change: +0.49 (3.38%)
Volume: 402.5 K
4:00PM ET 1/14/2022

Ocugen Inc ( NASDAQ )

Price: $4.25
Change: +0.23 (5.72%)
Volume: 11.9 M
4:00PM ET 1/14/2022

Rubius Therapeutics Inc ( NASDAQ )

Price: $8.82
Change: -0.01 (0.11%)
Volume: 464.4 K
4:00PM ET 1/14/2022

Agenus Inc ( NASDAQ )

Price: $3.05
Change: +0.16 (5.54%)
Volume: 3.8 M
4:00PM ET 1/14/2022

Read more news Recent News

MeiraGTx Holdings Reports Positive Preliminary Data From Trial of Potential Treatment for Radiation-Induced Xerostomia
7:54AM ET 12/07/2021 MT Newswires

MeiraGTx Holdings (MGTX) on Tuesday reported positive preliminary data from a phase 1 trial of AAV-hAQP1 to treat grade 2/3 radiation-induced xerostomia, a...

MeiraGTx Holdings Q3 Loss Deepens, Revenue Rises
10:14AM ET 11/10/2021 MT Newswires

MeiraGTx Holdings (MGTX), a clinical stage gene therapy company, reported Wednesday a Q3 diluted net loss of $0.59 per share, compared with a $0.17 loss a...

Insider Sell: Meiragtx Holdings
5:40PM ET 10/21/2021 MT Newswires

Richard Giroux, CFO & COO, on October 19, 2021, sold 22,000 shares in Meiragtx Holdings (MGTX) for $461,777. Following the Form 4 filing with the SEC,...

Insider Sell: Meiragtx Holdings
5:49PM ET 10/20/2021 MT Newswires

Alexandria Forbes, Director, President and CEO, on October 18, 2021, sold 30,000 shares in Meiragtx Holdings (MGTX) for $520,687. Following the Form 4...

View all Commentary and Analysis

MeiraGTx: Novel Riboswitch Technology Could Add Value
3:44PM ET 11/01/2021 Seeking Alpha

Wall Street Breakfast: What Moved Markets
8:23AM ET 10/23/2021 Seeking Alpha

Wall Street Breakfast: The Week Ahead (Podcast)
7:31AM ET 10/17/2021 Seeking Alpha

Wall Street Breakfast: The Week Ahead
7:11AM ET 10/17/2021 Seeking Alpha

Company Profile

Business DescriptionMeiraGTx Holdings Plc engages in the development of novel gene therapy treatments. It focuses on inherited retinal diseases, neurodegenerative diseases, and severe forms of xerostomia. It operates through the following geographical segments: United States, Ireland, Netherlands, and United Kingdom. Its pipeline includes AAV CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1 and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY. View company web site for more details
Address430 East 29th Street
New York, New York 10016
Number of Employees68
Recent SEC Filing01/11/20224
President, Chief Executive Officer & DirectorAlexandria Forbes
Chief Operating & Financial OfficerRichard Giroux
Chief Medical OfficerRobert K. Zeldin
Chief Development OfficerStuart Naylor

Company Highlights

Price Open$18.68
Previous Close$18.91
52 Week Range$11.60 - 24.89
Market Capitalization$821.8 M
Shares Outstanding44.4 M
SectorHealth Technology
Next Earnings Announcement03/10/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.83
Beta vs. S&P 500N/A
Net Profit Margin-391.81%
Return on Equity-37.57%

Analyst Ratings as of 11/10/2021

Consensus RecommendationConsensus Icon
Powered by Factset